Amount Raised
$25 Million
Round Type
Venture
BerkeleyBiotechnologyDescription
Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Pfizer Inc. (NYSE: PFE) has made a $25 million equity investment in the company. Pfizer purchased 4,690,431 of Caribou common shares at a price of $5.33 per share, pursuant to the terms of a Securities Purchase Agreement dated June 29, 2023
Who else raised in Biotechnology around the same time
Companies in the same sectors as Caribou that raised within 45 days of this round, from Fundz verified event records.
- Eupraxia Pharmaceuticals raised $128K (Pre-Seed) on August 18, 2023.
- Mendaera raised $24M (Funding Round) on August 18, 2023.
- Lightcast Discovery raised $49M (Funding Round) on August 18, 2023.
- Viome raised $87M (Funding Round) on August 18, 2023.
- COMPASS Pathways raised an undisclosed amount (Funding Round) on August 18, 2023.
- Rebalance Health, Inc. raised $7.4M on August 18, 2023.
Who to call at Caribou, and when
A new round usually means Caribou is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Caribou raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Caribou, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Caribou. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Caribou raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Caribou raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.